Tesamorelin (5Mg)
Growth Hormone-Releasing Peptide
Tesamorelin is a synthetic analog of GHRH that promotes the natural release of growth hormone and has shown clinical effectiveness in reducing visceral fat.
Usage:
Commonly used in research focused on lipodystrophy, particularly in HIV patients, and explored for cognitive and metabolic benefits.
Mechanism of Action:
Stimulates the pituitary gland to secrete growth hormone by binding to GHRH receptors.
Benefits:
- Reduces visceral adipose tissue
- Enhances GH secretion
- May improve lipid profiles
- Supports cognitive function
Side Effects:
- Injection site redness
- Water retention
- Tingling or numbness in extremities
Suggested Dosage:
Not specified
Half-life: Approximately 20–30 minutes
Delivery: Subcutaneous injection